RAPS Euro Convergence provides essential knowledge in the medical device, IVD, pharmaceutical industries, and regulatory business that will prepare you to successfully navigate the EU regulatory landscape.
RAPS Euro Convergence 2023 will focus on Harmonisation Through Regulatory Confluence
The regulatory affairs profession has seen a significant increase in regulations surrounding healthcare products—not only in the EU but across the globe. As such, this drives diverse interpretations and implementations in country and market strategies. Now more than ever, stakeholders across medical devices, IVDs, pharmaceuticals, and combination products must come together for open exchanges to manage the availability of safe and effective patient care.
RAPS Euro Convergence 2023 will focus on uniting global regulators, notified bodies, competent authorities, key opinion leaders, patient interest groups, and industry partners to explore varying perspectives about the current regulatory landscape and MDR/IVDR rollouts. Across three days of interactive discussions, the hope is to achieve a confluence among stakeholders that accelerates innovation.
Don’t miss the opportunity to contribute and engage in this critical dialogue. Register today to attend RAPS Euro Convergence 2023!
2023 RAPS Euro Convergence Programme Committee
Head of IVD Notified Body,
BSI Group The Netherlands B.V.
Vice President, Technical,
Robert Van Boxtel
Principal Consultant Medical Device Project B.V.
Giovanni Di Rienzo
Consultant Regulatory Affairs
Executive Director and Partner, QServe Group
Sabina Hoekstra-van den Bosch
Regulatory Strategy Principal, TÜV SÜD
Susana de Azevedo Wäsch
Vice President Quality Management and Regulatory Affairs, Ypsomed
Manager, Strategic Development, Centre for Innovation in Regulatory Science
Life Sciences expert in Regulatory & QA solutions
CEO and Senior Consultant, mi-CE Consultancy
Associate Director, Global Regulatory Affairs, Established Products, Alexion Pharmaceuticals
Senior Regulatory Affairs Manager, Philips International B.V.
Director, Scientific, Clinical & Regulatory Affairs, bitop AG
Senior Director, Haleon
Sabine Haubenreisser (EMA)
Principal Scientific Administrator, European Medicines Agency